Randomized Clinical Trial for Tonsil Surgery in Adults With Obstructive Sleep Apnea and Enlarged Tonsils

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorTurku University Hospital

About this trial

The aim is to investigate whether the tissue-preserving tonsil surgery technique is as effective as complete tonsil removal in the treatment of obstructive sleep apnea. The primary outcome measure is the change in the apnea-hypopnea index (AHI) before surgery and at 4-6, 24, and 60 months after surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

BMI < 35

Tonsil size 2 - 4

Otherwise healthy patient fit for tonsil surgery

Apnea-hypopnea index > 15

Disqualifiers

Pathological hemostasis or use of anticoagulation

Craniofacial deformities

Neurological condition with muscular hypotonia

Other surgical treatment for OSA

Trial design

Design model

Parallel

Treatments tested in this trial

  • Tonsillectomy

    Procedure/Surgery

    TE will be performed by dissection in the peritonsillar plane. Parts of the upper and lateral palatal mucosal arches will be incised, and an extracapsular dissection for complete tonsil excision will be performed.

  • Tonsillotomy

    Procedure/Surgery

    TT will be performed by removing approximately 60 - 90% of the tonsillar tissue, leaving a rim of tonsillar tissue on the tonsillar fossae. The tonsil capsule will not be breached.

Treatment groups

132 Participants
are divided into 2 treatment groups
Group A: TonsillectomyActive comparator 1 intervention
Group B: TonsillotomyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Changes in AHI at baseline and after surgery

The primary outcome is changes in AHI measured with home sleep study

Time frame
baseline, 4-6, 24 and 60 months after surgery.

Secondary outcomes

1

Daytime sleepiness

Measured with Epworth Sleepiness Scale (ESS) questionnaire (patient-reported). Points 0-18, higher is worse.

Time frame
Baseline and 6, 12, 24 and 60 months after surgery
2

Changes in insomnia symptoms

Measured with Insomnia Severity Index (ISI) questionnaire, points range 0-28, higher is worse.

Time frame
Baseline and 6, 12, 24 and 60 months after surgery
3

Surgical success rate

Defined according to Sher's criteria: a reduction in AHI of \>50% and a total AHI of \<20 after surgery

Time frame
Baseline and 6, 12, 24 and 60 months after surgery
4

Surgical cure rate

Defined as a total AHI of \<5 after surgery

Time frame
Baseline and 6, 12, 24 and 60 months after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Turku University Hospital

Lead sponsor

Tampere University Hospital

Collaborator

Oulu University Hospital

Collaborator

Helsinki University Central Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: